Skip to main content
Canadian Journal of Dental Hygiene logoLink to Canadian Journal of Dental Hygiene
. 2024 Jun 1;58(2):98–105.

Controversies regarding oral lichen planus and lichenoid-dysplastic lesions

Ilena S Yim * , § , Lewei Zhang * , § , , Iris Lin * , § , Denise M Laronde * , §
PMCID: PMC11223637  PMID: 38974821

Abstract

Objective:

Oral lichen planus (OLP) is an immune-mediated condition featuring chronic inflammation. The World Health Organization classifies OLP as potentially malignant, but it is believed that the malignant transformation of OLP occurs in lesions with both lichenoid and dysplastic features (LD). This review discusses the issues surrounding OLP and LD, including their malignancy, classification, and categorization, and whether lichenoid inflammation causes dysplastic changes in LD or vice versa.

Methods:

English full-text literature on OLP, LD and/or dysplasia was retrieved from PubMed, CINAHL, and Google Scholar.

Results:

Thirty-six publications including original research articles, reviews, meta-analyses, books, reports, letters, and editorials were selected for review.

Discussion:

Research suggests that OLP has malignant potential, although small, and that LD should not be disregarded, as dysplasia presenting with or without lichenoid features may develop into cancer. There is also disagreement over the classification and categorization of LD. Different terms have been used to classify these lesions, including lichenoid dysplasia, OLP with dysplasia, and dysplasia with lichenoid features. Moreover, in LD, it is not clear if dysplasia or lichenoid infiltration appears first, and if inflammation is a response to dysplasia or if dysplasia is a response to the persistent inflammation. The main limitation in the literature is the inconsistency and subjective nature of histological diagnoses, which can lead to interobserver and intraobserver variation, ultimately resulting in the inaccurate diagnosis of OLP and LD.

Conclusion:

Although further research is required to understand OLP and LD, both lesions should be considered potentially malignant and should not be disregarded.

Keywords: malignant transformation, mouth, neoplasms, oral epithelial dysplasia, oral lichen planus, oral lichenoid dysplasia, risk


PRACTICAL IMPLICATIONS OF THIS RESEARCH.

  • Greater familiarity with the literature and controversies surrounding the malignant potential of oral lichen planus and lesions with both lichenoid and dysplastic features can help raise awareness of such lesions.

  • Understanding the malignant potential of oral lichen planus and lesions with both lichenoid and dysplastic features highlights the importance of monitoring and following-up such lesions for prevention and early detection of oral malignancy.

INTRODUCTION

Oral lichen planus (OLP) is an immune-mediated condition characterized by chronic inflammation.1 It has a global prevalence of 1.01% and is highly prevalent in the middle-aged population, especially among women.24 The most common clinical presentations of OLP are bilateral white lesions, with variants including reticular, papular, plaque-like, erosive, atrophic or erythematous, and bulbous forms.2, 3 OLP is most commonly located on the buccal mucosa, tongue, and gingiva, with the tongue being associated with the highest rates of malignant transformation.2, 5, 6

Histologically, mucosal lesions with a band-like area of lymphocytic infiltrate in the subepithelium and liquefactive degeneration in the basal cell layer of the tissue are called lichenoid lesions.3, 7, 8 These include not only OLP, but also lupus erythematous, graft versus host disease, and lichenoid mucositis. OLP is often confused with oral lichenoid mucositis.911 Not only is oral lichenoid mucositis histologically similar to OLP, but it can also have a similar or indistinguishable clinical appearance to OLP.12, 13 OLP, however, is a chronic condition, whereas lichenoid mucositis resolves after removal of allergens such as dental filling material or systemic drugs.9, 10 To further confuse the issue, the terms lichenoid mucositis and lichenoid lesion are used interchangeably; the actual meaning can only be discerned from the context.12, 13

The World Health Organization (WHO) considers OLP a potentially malignant condition, although this position is controversial.10 Others believe that only OLP with dysplasia is a potentially malignant variant of OLP.14, 15 They suggest that previous reports of the malignant transformation of OLP had occurred in lesions with both lichenoid and dysplastic features (LD).14, 15 This review aims to provide clinicians and researchers with a clearer understanding of the issues surrounding OLP and LD, including malignancy, classification and categorization, and the possibility that lichenoid inflammation causes dysplastic changes in LD or vice versa.

METHODS

PubMed, CINAHL, and Google Scholar were searched for full-text literature using the keywords oral lichen planus, lichenoid dysplasia, lichenoid, dysplasia, oral cancer, malig*, progression, and transformation. No restrictions were placed on the date of publication in order to identify the progression of information. To capture various views, opinions, and evidence on this controversial topic, no restrictions were placed on types of literature selected. Articles not published in English were excluded.

RESULTS

Sixteen original research articles (1 case series, 1 case–control, 4 coh ort, and 10 cross-sectional studies); 10 literature, narrative, and scoping reviews; 2 systematic reviews; 1 systematic review with meta-analysis; 1 meta-analysis; 1 book; 2 case reports; 2 reports; 1 letter to the editor; and 1 editorial regarding OLP, LD and/or dysplasia were selected. The literature shows that both OLP and LD have malignant potential, but there is still a lack of agreement on the classification and categorization of LD. It is also still unclear whether inflammation is a response to dysplastic change or if inflammation induces dysplastic change.

DISCUSSION

Malignant profile of OLP and LD

Is OLP malignant?

The controversy surrounding the malignant potential of OLP persists due to the lack of uniform and distinct clinical and histopathological diagnostic criteria.10 In 1978, Krutchkoff et al.14 published a review examining 223 reported malignant transformations of OLP. Due to the unreliable diagnostic criteria, they proposed that the malignant cases of OLP may have been dysplastic lesions with lichenoid features, hence raising the rate of OLP transformation.14 In 1989, Lovas et al.15 analysed 3 cases of clinically and histologically diagnosed OLP. Two cases of OLP were in fact epithelial dysplasia with lichenoid infiltrate. The authors claimed that the malignant transformation of OLP might instead be the transformation of dysplastic lesions that clinically and histologically mimic OLP.15 To create a more distinct criterion for OLP, van der Meij and van der Waal modified the 1978 WHO diagnostic criterion in 2003 to exclude cases of LD.7, 8 The modification required the histopathological absence of epithelial dysplasia for a diagnosis of OLP.7, 8 The American Academy of Oral and Maxillofacial Pathology supports this criterion and adds that both clinical and histopathological criteria should be fulfilled for a diagnosis of OLP.16 Specifically, a histopathological diagnosis of OLP should require the absence of verrucous epithelium.16 However, the dispute over the malignant potential of OLP persists.

Malignant transformation of OLP

Literature shows that the malignant transformation rate (MTR) of OLP without dysplasia ranges from 1% to 1.5%.2, 6, 17 Case selection may play a large role in the controversy surrounding the malignant progression of OLP. In their systemic reviews, Fitzpatrick et al.6 and Giuliani et al.17 selected studies that excluded epithelial dysplasia on initial diagnosis of OLP. Lesions with both dysplastic and lichenoid features can result in false positive cases of malignant OLP.6, 17 Aghbari et al.2 stated in their meta-analysis that the diagnosis of OLP was based on a defined criterion, preferably including a histological examination. However, they did not explicitly mention whether epithelial dysplasia was excluded.2 Of the 7806 cases of OLP studied by Fitzpatrick et al.6 85 developed oral squamous cell carcinoma (OSCC), resulting in a MTR of 1.09%. In the study by Giuliani et al.17 87 of the 6353 cases of OLP developed OSCC, which resulted in a MTR of 1.37%. Aghbari et al.2 selected 19,676 cases of OLP, 280 of which developed OSCC (1.42% MTR). These authors demonstrate the possible malignant potential of OLP. Table 1 shows the MTR for OLP and LD across different studies.

Table 1.

Malignant transformation rate of oral lichen planus and lesions with both lichenoid and dysplastic features

 

OLP

 

 

LD

 

 

Total

 

Cases

Progressed casesa

MTR (%)

Cases

Progressed casesa

MTR (%)

Cases

Fitzpatrick et al. (2014)6

7806

85

1.09

N/A

N/A

N/A

7806

Giuliani et al. (2019)17

6353

87

1.37

N/A

N/A

N/A

6353

Aghbari et al. (2017)2

19,676

280

1.42

N/A

N/A

N/A

19,676

               

Shearston et al. (2019)21

206

1

0.49

44

3

6.81

250

Bornstein et al. (2006)22

138

1

0.71

3

3

100.00

141

Irani et al. (2016)23

100

0

0

12

1

8.33

112

Bandyopadhyay et al. (2017)1

132

0

0

11

2

18.18

143

               

Rock et al. (2018)24

N/A

N/A

N/A

73

6b

8.22

73

OLP: oral lichen planus; LD: lichenoid and dysplastic features; MTR: malignant transformation rate

aProgression to oral squamous cell carcinoma unless otherwise indicated

bProgression to oral severe dysplasia, carcinoma in situ, or squamous cell carcinoma

Coexistence of lichenoid and dysplastic features

As stated previously, it is believed that the malignant transformation of OLP occurs in lesions with both lichenoid and dysplastic features. Several authors have studied the coexistence of these features.18, 19 Fitzpatrick et al.18 studied 352 cases of mild to moderate dysplasia, severe dysplasia or carcinoma in situ (CIS), and OSCC.18 They found that 29% of those cases had 3 or more of the 5 lichenoid features focally present (Table 2). Specifically, 39% of mild to moderate dysplasia, 16% of severe dysplasia or CIS, and 34% of OSCC cases showed 3 or more lichenoid features focally present.18 Patil et al.19 retrospectively reviewed cases of OLP and oral epithelial dysplasia (OED) and found that 8 of the 54 OLP cases had epithelial dysplasia, whereas 22 of the 95 cases of OED presented with lichenoid features. These studies demonstrate that both lichenoid and dysplastic features can coexist, even at higher grades of dysplasia and SCC.18, 19 In higher grades of premalignancy and malignancy, it may be possible for pathologists to exclude reports of lichenoid features as the diagnosis of the lesion may depend on which histologic and cytologic characteristics are considered more important.20

Malignant transformation of OLP and LD

Several authors have studied the malignant transformation of OLP and LD. In their retrospective study, Shearston et al.21 reviewed OLP and LD. They referred to LD as oral lichenoid dysplasia and categorized this lesion separately from OLP. For oral lichenoid dysplasia, Shearston et al.21 required the presence of OED in OLP, or OED associated with lichenoid infiltrate. Bornstein et al.,22 Irani et al.,23 and Bandyopadhyay et al.1 also retrospectively studied the malignant progression of OLP. They classified LD as part of OLP, rather than as a separate entity such as oral lichenoid dysplasia, as had Shearston et al.1, 2123 In their study, Bornstein et al.22 included cases of OLP and cases of LD on initial diagnosis. The cases of OLP in the study by Irani et al.23 did not present with dysplasia on initial diagnosis but dysplasia developed in some cases of OLP after the initial diagnosis. Bandyopadhyay et al.1 did not specify whether dysplasia was present on initial diagnosis or had developed afterwards. In these studies, lesions with lichenoid and dysplastic features were found to progress to OSCC more frequently than OLP.1, 2123

Table 2.

Five histological lichenoid features included in the study by Fitzpatrick et al.18

Band-like infiltrate immediately subjacent to the epithelium

Sawtooth rete ridges formation

Interface stomatitis, or the infiltration of the basal layer of epithelium by lymphocytes

Formation of Civatte (colloid) bodies

Degeneration of basal layer

Table 3.

Histological diagnostic criteria of oral lichen planus by Krutchkoff and Eisenberg25

Requisite features

Liquefactive degeneration of basal cells

Bandlike infiltrate of lymphocytes within lamina propria that intimately intermingles with basal cell region of surface epithelium

Additional features

“Saw-toothed” rete pegs; a common variation is the presence of slender, indistinct, tapered rete pegs

Hyperkeratosis or parakeratosis

Separation of surface epithelium from underlying connective tissue with ragged, uneven plane of cleavage

Isolated individual cell keratinization within the prickle cell region (formation of so-called “Civatte bodies”)

Disqualifying features (features that, if present, preclude a definite diagnosis of lichen planus)

Topographic and cytologic features of dysplasia; these include any or all of the following:

  1. Significantly increased nuclear size (usually manifests as increased nucleus/cytoplasm ratio)

  2. Cellular pleomorphism

  3. Altered or disturbed epithelial maturation

  4. Nuclear hyperchromasia (beyond the range of normal)

  5. More than sporadic foci of premature or abnormal keratinization

  6. Abnormal mitotic figures

  7. Notable intercellular fluid accumulation or edema that accompanies any of the 6 preceding parameters

Presence of heterogeneous round cell inflammatory infiltrate within the lamina propria; the presence of substantial numbers of plasma cells, eosinophils, or neutrophils within the “bandlike” infiltrate is considered adequate grounds for disqualification

Diffuse extension of infiltrate to involve deeper submucosal tissues or frank perivascular distribution of infiltrate

Shearston et al.21 examined 206 cases of OLP with 1 case progressing to OSCC, resulting in a MTR of 0.49%. In comparison, 3 of the 44 oral lichenoid dysplasia cases developed OSCC, resulting in a MTR of 6.81%.21 Bornstein et al.22 included 141 OLP patients in total; 138 had OLP without dysplasia and 3 had OLP with dysplasia. One patient diagnosed with OLP without dysplasia developed OSCC simultaneously in 3 separate sites (0.71% MTR). All 3 cases of OLP with dysplasia developed OSCC (100% MTR).22 Irani et al.23 studied 112 cases of OLP, 100 without dysplasia and 12 with dysplasia. None of the cases without dysplasia developed OSCC (0% MTR), while one case with dysplasia developed OSCC (8.33% MTR).23 Bandyopadhyay et al.1 selected 143 patients with OLP; 132 without dysplasia and 11 with dysplasia.1 As in the Irani et al. study,23 none of the patients without dysplasia developed OSCC (0% MTR), whereas 2 patients with dysplasia developed OSCC (18.18% MTR). Overall, the literature shows that the MTR of OLP (without dysplasia) ranges from 0% to 1.5%; whereas the MTR of LD ranges from 6% to 100% (Table 1).1, 2, 6, 17, 2123 Although the number of cases of LD is small and the MTR range of these cases is large, the higher MTR as compared to OLP (without dysplasia) shows that LD has a higher malignant potential, and thus dysplastic changes should not be disregarded.

Rock et al.24 compared the MTR of dysplasia with and without lichenoid mucositis. In their study, lichenoid mucositis referred to lesions with lichenoid features.13 Progression was defined as progression to severe dysplasia, CIS or SCC.24 Six of the 73 cases of dysplasia with lichenoid mucositis progressed (8%), whereas 49 of the 373 cases of dysplasia without lichenoid mucositis progressed (13%) (Table 1). The progression rate between the 2 groups was found to be not significantly different. There was also no significant difference between the 3- and 5-year progression rate for these 2 groups. This study demonstrates that dysplasia whether presenting with or without lichenoid mucositis has a similar risk of cancer, further supporting the argument that LD should not be disregarded.24

Classification and categorization of LD

There is disagreement in the literature over the classification and categorization of LD. Various names have been used to classify these lesions, including lichenoid dysplasia, OLP with dysplasia, and dysplasia with lichenoid features.1, 2123, 2529 In addition to the confusing names, there has also been no agreement on the categorization of these lesions.

Table 4.

Histological features of dysplasia by Krutchkoff and Eisenberg25

Increased nucleus/cytoplasm ratio

Nuclear pleomorphism

Nuclear hyperchromasia

Disturbed or disorderly maturation

Lack of cellular cohesion, which often manifests as marked intercellular edema

Increased or abnormal mitoses

Blunted, club-shaped or “tear drop”-shaped rete pegs

Table 5.

Classification and categorization of lesions with both lichenoid and dysplastic features

Lichenoid dysplasia

 

Krutchkoff and Eisenberg (1985)25

“Lichenoid dysplasia” is a distinct histopathological entity from oral lichen planus (OLP). Lichenoid dysplasia describes lesions with both clinical lichenoid and histopathological lichenoid and dysplastic features.

Lodi et al. (2005)26

Lichenoid dysplasia includes 2 groups:

  1. Lesions clinically presenting as OLP and histologically with dysplasia. They represent early stages in the malignant transformation of OLP.

  2. Lesions that do not clinically resemble OLP but have lichenoid features histologically. They represent different clinical conditions associated with lichenoid histology.

Sanketh et al. (2017)27

Oral lichenoid dysplasia represents epithelial dysplastic lesions with lichenoid features, and these terms are interchangeable. Oral lichenoid dysplasia or epithelial dysplastic lesions with lichenoid features histologically presents with dysplasia and lichenoid features. OLP histologically presents with lichenoid features but can also manifest with dysplasia. Oral lichenoid dysplasia does not represent OLP with dysplasia as oral lichenoid dysplasia or epithelial dysplastic lesions with lichenoid features clinically presents with leukoplakia or erythroplakia, whereas OLP clinically appears as lichen planus.

OLP

 

Czerninski et al. (2015)28

OLP with dysplasia is part of the OLP spectrum and should not be classified into the separate category of lichenoid dysplasia.

Other (neither OLP nor lichenoid dysplasia)

 

Van der Meij and van der Waal (2003)7

Epithelial dysplasia is an exclusion criterion for the histopathological diagnosis of OLP. The term lichenoid dysplasia should not be used either.

Muller (2011)30

Lichenoid dysplasia should not be used to describe dysplastic lesions presenting with lichenoid histological features. The presence of dysplasia in a lichenoid lesion should not result in the diagnosis of OLP.

Raj et al. (2018)31

There are 2 subtypes for LD:

  1. Primary oral epithelial dysplasia with lichenoid features, presenting with dysplasia and inflammatory infiltrate regardless of basal cell degeneration.

  2. Primary OLP with secondary dysplastic features: a bilateral presentation, minor reticular component, dysplasia, lymphocytic infiltrate, and basal cell degeneration.

Lichenoid dysplasia

In 1978, when Krutchkoff and Eisenberg first proposed the term “lichenoid dysplasia,” they regarded it as a distinct histopathological entity from OLP (Table 3).25 Lichenoid dysplasia describes lesions with both clinical lichenoid and histopathological lichenoid and dysplastic features. The presence of 2 or more dysplastic features in the epithelium (Table 4) rules out the diagnosis of OLP regardless of how many lichenoid features are present.25

There is little agreement on what constitutes lichenoid dysplasia. Lodi et al.26 associate lichenoid dysplasia with 2 groups of conditions: 1) lesions that present clinically as OLP and histologically with dysplasia; 2) lesions that present with no clinical signs of OLP but have lichenoid and dysplastic features histologically. The first group may represent early stages in the malignant transformation of OLP, and the second group refers to various clinical co nditions associated with lichenoid histology.26 To confuse matters further, Sanketh et al.27 use the terms oral lichenoid dysplasia and epithelial dysplastic lesions with lichenoid features interchangeably. Although there are similar histological characteristics between oral lichenoid dysplasia (or epithelial dysplastic lesions with lichenoid features) and OLP, in their opinion, oral lichenoid dysplasia is not equivalent to OLP.27 Oral lichenoid dysplasia or epithelial dysplastic lesions with lichenoid features is clinical leukoplakia or erythroplakia that histologically presents with dysplastic and lichenoid features, whereas OLP histologically presents with lichenoid features and may have dysplasia, but clinically appears as lichen planus.27

Other classifications

Other authors indicate that the term lichenoid dysplasia should not be used. The WHO does not use the term lichenoid dysplasia,10 preferring to describe LD in terms of oral lichenoid lesions or OLP with or without dysplasia.9 Czerninski et al.28 believe that OLP with dysplasia is part of the OLP spectrum and should not be classified into the separate category of lichenoid dysplasia.28 In contrast, van der Meij and van der Waal7 regard the presence of epithelial dysplasia as an exclusion criterion for the histopathological diagnosis of OLP, but also refrain from using the term lichenoid dysplasia. Similarly, Muller30 avoids diagnosing dysplastic lesions presenting with lichenoid histological features as lichenoid dysplasia or OLP.

Interestingly, Raj et al.31 proposed 2 subtypes of LD. The first subtype is primary OED with lichenoid features, which presents with dysplasia and inflammatory infiltrate regardless of basal cell degeneration. The second subtype is primary OLP with secondary dysplastic features, which clinically has a bilateral presentation and minor reticular component, and histologically, dysplasia, lymphocytic infiltrate, and basal cell degeneration.31 Table 5 presents a summary of the various classifications and categorizations of LD.

Does dysplasia cause inflammation or vice versa?

In lesions with both dysplastic and lichenoid features, does epithelial dysplasia cause lichenoid inflammation? Or does lichenoid inflammation cause dysplasia? Or is there no relationship between the inflammation and dysplasia observed?

Theory 1: Inflammation is a response to dysplasia

Lichenoid inflammatory infiltrate can represent an immunologic response to antigenic modification of the epithelium.3234 In dysplastic epithelium, the infiltrate may represent an immune response to neoantigens present.33 In OLP, the infiltrate is dominated by T lymphocytes, whereas in LD, the infiltrate is composed of a mixture of lymphocytes and plasma cells.30 Eisenberg33 states that the nature of the antigen controls the composition of the lichenoid infiltrate, and thus the infiltrate must be carefully examined as it may indicate whether a lesion has malignant potential.

The ratio of T lymphocytes may also be an important feature to note. Flores-Hidalgo et al.29 found that, in OED with lichenoid features, there is an increased CD8+ to CD4+ lymphocyte ratio, while in OLP, there are similar quantities of each cell type. The inflammatory infiltrate changes from a regulatory or suppressive function in OLP to a cytotoxic function in OED with lichenoid inflammation as the CD8+ cells try to eliminate epithelial cells undergoing malignant transformation. This suggests that dysplasia may initiate infiltrate that is specific to lesions with lichenoid and dysplastic features. As a result, OED with lichenoid features may have greater malignant potential than OLP due to differences in cellular activity.29 Other authors also support the belief that lichenoid inflammation is an immune response to dysplasia.18, 35, 36 Of interest, Fitzpatrick et al.18 observed a loss of lichenoid features as the grade of dysplasia in LD progressed from low to high.

Theory 2: Dysplasia is a response to inflammation

Some authors believe that the inflammatory hallmark of OLP, the lichenoid infiltrate, can induce histologic features similar to dysplasia.26 Inflammatory actions via inflammatory cells (e.g., certain macrophage types, mast cells, neutrophils, and B and T lymphocytes) were once thought to eliminate tumours, but these responses may have an opposite effect by enhancing tumourigenesis and progression.32 T lymphocytes, which are expressed in OLP inflammatory infiltrate, release inflammatory factors related with cancer initiation, progression, and invasion.37 It has been hypothesized that the inflammatory infiltrate may produce oxidative stress, cytokines, and transcription factor signals that can cause abnormal cellular replication, DNA damage, and disordered epithelial integrity.37 The liquefactive degeneration of the basal cells as well as apoptosis would increase cell proliferation, which is positively correlated with cellular mutation. These events can lead to epithelial changes associated with dysplasia and cancer over time, resulting in the malignant transformation of OLP.37, 38

Theory 3: Lichenoid lesion develops dysplasia

It is possible that there is no cause-and-effect relationship between the inflammation and dysplasia observed in a lesion. Lichenoid lesions could develop dysplasia when the mucosa is exposed to a carcinogen, such as tobacco.

Gaps in the research

The greatest limitation in the literature on oral lesions, including those with lichenoid and dysplastic features, is accurate diagnosis.2, 18, 19 Fischer et al.39 suggest that the presence of inflammation, such as inflammation in lichenoid lesions, may reduce a pathologist’s ability to observe dysplastic changes. The subjective nature of histologic diagnoses often results in interobserver and intraobserver variation, which can lead to the inaccurate diagnosis of dysplastic and lichenoid features.4042 The diagnostic variability between pathologists and within a pathologist arises from the lack of objective diagnostic criteria.42 In addition, clinical information about the lesion, although needed, may be missing when tissue specimens are submitted for diagnosis.

Several authors have assessed interobserver and intraobserver variability in the diagnosis of dysplasia and OLP, with the majority showing greater intraobserver agreement than interobserver agreement.20, 40, 43, 44 In Abbey et al.’s study,40 agreement with the original diagnosis of the presence of dysplasia was around 80%. When pathologists diagnosed the same biopsies again several months later, intraobserver agreement was also 80%.40 In the study by Karabulut et al.20 there was poor to moderate interobserver agreement in grading tissue from an absence of dysplasia to CIS. Van der Meij et al.43 assessed interobserver variability in the diagnosis of OLP using the WHO definition of OLP. As with the diagnosis of dysplasia in other studies, there was poor to moderate interobserver agreement (0.20 to 0.51) in the diagnosis of OLP. Intraobserver agreement was greater, with moderate to substantial agreement (0.50 to 0.67).43 Zohdy et al.44 studied the interobserver and intraobserver variability in the diagnosis of dysplasia in OLP and oral lichenoid lesions. The results of 4 examiners were compared, as well as individual results 3 months later. Similar to the above-mentioned studies, there was low interobserver reliability among the 4 examiners, but fair to substantial intraobserver reliability. Zohdy et al.44 thus proposed the possible use of a binary system to evaluate dysplasia in such oral lesions. Interestingly, a higher grade of dysplasia was diagnosed in oral lichenoid lesions than OLP.44 Future research to support accurate histological diagnoses of LD and OLP is required to help reduce the controversies surrounding LD and OLP in the literature.

CONCLUSION

The malignant potential of OLP, a condition characterized by chronic inflammation, is subject to controversy as some authors argue that the malignant progression occurs in LD rather than OLP. Systematic reviews and retrospective studies of OLP and LD have demonstrated that the MTR of OLP ranges from 0% to 1.5%, suggesting that OLP does have malignant potential, although small. LD has malignant potential based on the range of its MTR (6% to 100%) and should not be disregarded. However, there is still debate over the classification and categorization of LD. Various names have been used, including lichenoid dysplasia, OLP with dysplasia, and dysplasia with lichenoid features. Some authors consider these lesions as part of the distinct entity lichenoid dysplasia, part of the OLP spectrum, neither part of OLP nor lichenoid dysplasia, or part of both OED and OLP.

Furthermore, in LD, there are unanswered questions. Does epithelial dysplasia or lichenoid infiltrate appear first? Is the inflammation a response to dysplastic changes in the epithelium? Vice versa? Or both? Regardless of which change appears first, or which change induces the other, both features appear to be associated with malignancy. Currently, the main limitation in the research is the inaccurate diagnosis of OLP and LD due to the subjective nature of histologic diagnoses, which often results in interobserver and intraobserver variation. Although more research is required to understand the relationship between OLP and LD, and their malignant risk, both lesions should be considered potentially malignant and should not be disregarded in clinical practice.

CONFLICTS OF INTEREST

The authors have declared no conflicts of interest.

Acknowledgments

This work was supported by a grant from the Canadian Foundation for Dental Hygiene Research and Education (CFDHRE). IY was supported by a University of British Columbia Faculty of Dentistry 2019 summer studentship.

Footnotes

CDHA Research Agenda category: risk assessment and management

References

  1. Bandyopadhyay A , Behura SS , Nishat R , Dash KC , Bhuyan L , Ramachandra S Clinicopathological profile and malignant transformation in oral lichen planus: a retrospective study J Int Prev Community Dent 2017 ; 7 ( 3 ): 116 – 124 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aghbari SMH , Abushouk AI , Attia A , Elmaraezy A , Menshawy A , Ahmed MS , et al. Malignant transformation of oral lichen planus and oral lichenoid lesions: a meta-analysis of 20095 patient data Oral Oncol 2017 ; 68 : 92 – 102 [DOI] [PubMed] [Google Scholar]
  3. Regezi JA , Sciubba J , Jordan RCK . Oral pathology: clinical pathologic correlations . 7th ed. St. Louis (MO) : : Elsevier ; ; 2017 . [Google Scholar]
  4. González-Moles MÁ , Warnakulasuriya S , González-Ruiz I , González-Ruiz L , Ayén Á , Lenouvel D , et al. Worldwide prevalence of oral lichen planus: a systematic review and meta-analysis Oral Dis 2021 ; 27 ( 4 ): 813 – 828 [DOI] [PubMed] [Google Scholar]
  5. Olson MA , Rogers RS , Bruce AJ Oral lichen planus Clin Dermatol 2016 ; 34 ( 4 ): 495 – 504 [DOI] [PubMed] [Google Scholar]
  6. Fitzpatrick SG , Hirsch SA , Gordon SC The malignant transformation of oral lichen planus and oral lichenoid lesions: a systematic review J Am Dent Assoc 2014 ; 145 ( 1 ): 45 – 56 [DOI] [PubMed] [Google Scholar]
  7. Van der Meij EH , Van der Waal I Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications J Oral Pathol Med 2003 ; 32 ( 9 ): 507 – 512 [DOI] [PubMed] [Google Scholar]
  8. Kramer IR , Lucas RB , Pindborg JJ , Sobin LH Definition of leukoplakia and related lesions: an aid to studies on oral precancer Oral Surg Oral Med Oral Pathol 1978 ; 46 ( 4 ): 518 – 539 [PubMed] [Google Scholar]
  9. Van der Waal I Oral lichen planus and oral lichenoid lesions: a critical appraisal with emphasis on the diagnostic aspects Med Oral Patol Oral Cir Bucal 2009 ; 14 ( 7 ): E310–E314 [PubMed] [Google Scholar]
  10. Barnes L , Eveson J , Reichart P , Sidransky D . Pathology and genetics of head and neck tumours . 3rd ed. Lyon, France : : IARC Press ; ; 2005 . [Google Scholar]
  11. De Rossi SS , Ciarrocca K Oral lichen planus and lichenoid mucositis Dent Clin North Am 2014 ; 58 ( 2 ): 299 – 313 [DOI] [PubMed] [Google Scholar]
  12. Raj AT , Patil S , Gupta AA True nature of mild epithelial dysplasia in oral lichenoid mucositis—Is it a reactionary change to the sub-epithelial inflammation or represents true malignant potential? A hypothesis Med Hypotheses 2018 ; 120 : 48 [DOI] [PubMed] [Google Scholar]
  13. Zhang L , Rock LD , Rosin MP , Laronde DM Dysplasia and lichenoid mucositis: the chicken or the egg? J Dent Res 2018 ; 97 ( 10 ): 1179 [DOI] [PubMed] [Google Scholar]
  14. Krutchkoff DJ , Cutler L , Laskowski S Oral lichen planus: the evidence regarding potential malignant transformation J Oral Pathol 1978 ; 7 ( 1 ): 1 – 7 [DOI] [PubMed] [Google Scholar]
  15. Lovas JGL , Harsanyi BB , ElGeneidy AK Oral lichenoid dysplasia: a clinicopathologic analysis Oral Surg Oral Med Oral Pathol 1989 ; 68 ( 1 ): 57 – 63 [DOI] [PubMed] [Google Scholar]
  16. Cheng YSL , Gould A , Kurago Z , Fantasia J , Muller S Diagnosis of oral lichen planus: a position paper of the American Academy of Oral and Maxillofacial Pathology Oral Surg Oral Med Oral Pathol Oral Radiol 2016 ; 122 ( 3 ): 332 – 354 [DOI] [PubMed] [Google Scholar]
  17. Giuliani M , Troiano G , Cordaro M , Corsalini M , Gioco G , Lo Muzio L , et al. Rate of malignant transformation of oral lichen planus: a systematic review Oral Dis 2019 ; 25 ( 3 ): 693 – 709 [DOI] [PubMed] [Google Scholar]
  18. Fitzpatrick SG , Honda KS , Sattar A , Hirsch SA Histologic lichenoid features in oral dysplasia and squamous cell carcinoma Oral Surg Oral Med Oral Pathol Oral Radiol 2014 ; 117 ( 4 ): 511 – 520 [DOI] [PubMed] [Google Scholar]
  19. Patil S , Rao RS , Sanketh DS , Warnakulasuriya S Lichenoid dysplasia revisited: evidence from a review of Indian archives J Oral Pathol Med 2015 ; 44 ( 7 ): 507 – 514 [DOI] [PubMed] [Google Scholar]
  20. Karabulut A , Reibel J , Therkildsen MH , Praetorius F , Nielsen HW , Dabelsteen E Observer variability in the histologic assessment of oral premalignant lesions J Oral Pathol Med 1995 ; 24 ( 5 ): 198 – 200 [DOI] [PubMed] [Google Scholar]
  21. Shearston K , Fateh B , Tai S , Hove D , Farah CS Oral lichenoid dysplasia and not oral lichen planus undergoes malignant transformation at high rates J Oral Pathol Med 2019 ; 48 ( 7 ): 538 – 545 [DOI] [PubMed] [Google Scholar]
  22. Bornstein M , Kalas L , Lemp S , Altermatt H , Rees T , Buser D Oral lichen planus and malignant transformation: a retrospective follow-up study of clinical and histopathologic data Quintessence Int (Berl) 2006 ; 37 ( 4 ): 261 – 271 [PubMed] [Google Scholar]
  23. Irani S , Esfahani A , Ghorbani A Dysplastic change rate in cases of oral lichen planus: a retrospective study of 112 cases in an Iranian population J Oral Maxillofac Pathol 2016 ; 20 ( 3 ): 395 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rock LD , Laronde DM , Lin I , Rosin MP , Chan B , Shariati B , et al. Dysplasia should not be ignored in lichenoid mucositis J Dent Res 2018 ; 97 ( 7 ): 767 – 772 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Krutchkoff DJ , Eisenberg E Lichenoid dysplasia: a distinct histopathologic entity Oral Surg Oral Med Oral Pathol 1985 ; 60 ( 3 ): 308 – 315 [DOI] [PubMed] [Google Scholar]
  26. Lodi G , Scully C , Carrozzo M , Griffiths M , Sugerman PB , Thongprasom K Current controversies in oral lichen planus: report of an international consensus meeting. Part 2. Clinical management and malignant transformation Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005 ; 100 ( 2 ): 164 – 178 [DOI] [PubMed] [Google Scholar]
  27. Sanketh DSK , Patil S , Swetha B Oral lichen planus and epithelial dysplasia with lichenoid features: a review and discussion with special reference to diagnosis J Investig Clin Dent 2017 ; 8 ( 3 ) [DOI] [PubMed] [Google Scholar]
  28. Czerninski R , Zeituni S , Maly A , Basile J Clinical characteristics of lichen and dysplasia vs lichen planus cases and dysplasia cases Oral Dis 2015 ; 21 ( 4 ): 478 – 482 [DOI] [PubMed] [Google Scholar]
  29. Flores-Hidalgo A , Murrah V , Fedoriw Y , Padilla RJ Relationship of infiltrating intraepithelial T lymphocytes in the diagnosis of oral lichen planus versus oral epithelial dysplasia: a pilot study Oral Surg Oral Med Oral Pathol Oral Radiol 2019 ; 127 ( 6 ): e123 – e135 [DOI] [PubMed] [Google Scholar]
  30. Müller S The lichenoid tissue reactions of the oral mucosa: oral lichen planus and other lichenoid lesions Surg Pathol Clin 2011 ; 4 ( 4 ): 1005 – 1026 [DOI] [PubMed] [Google Scholar]
  31. Raj AT , Patil S , Sarode GS , Sarode SC , Awan KH Letter to the editor: “Dysplasia should not be ignored in lichenoid mucositis” J Dent Res 2018 ; 97 ( 10 ): 1178 [DOI] [PubMed] [Google Scholar]
  32. Hanahan D , Weinberg RA Hallmarks of cancer: the next generation Cell 2011 ; 144 ( 5 ): 646 – 674 [DOI] [PubMed] [Google Scholar]
  33. Eisenberg E Oral lichen planus: a benign lesion J Oral Maxillofac Surg 2000 ; 58 ( 11 ): 1278 – 1285 [DOI] [PubMed] [Google Scholar]
  34. Eisenberg E , Krutchkoff DJ Lichenoid lesions of oral mucosa. Diagnostic criteria and their importance in the alleged relationship to oral cancer Oral Surg Oral Med Oral Pathol 1992 ; 73 ( 6 ): 699 – 704 [DOI] [PubMed] [Google Scholar]
  35. Thomson PJ , Goodson ML , Smith DR Potentially malignant disorders revisited—The lichenoid lesion/proliferative verrucous leukoplakia conundrum J Oral Pathol Med 2018 ; 47 ( 6 ): 557 – 565 [DOI] [PubMed] [Google Scholar]
  36. Eversole LR Diseases should not be considered entities unto themselves Oral Surg Oral Med Oral Pathol 1992 ; 73 ( 6 ): 707 [DOI] [PubMed] [Google Scholar]
  37. Mignogna MD , Fedele S , Lo Russo L , Lo Muzio L , Bucci E Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence? Oral Oncol 2004 ; 40 ( 2 ): 120 – 130 [DOI] [PubMed] [Google Scholar]
  38. Georgakopoulou EA , Achtari MD , Achtaris M , Foukas PG , Kotsinas A Oral lichen planus as a preneoplastic inflammatory model J Biomed Biotechnol 2012 ; 2012 : 759626 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Fischer DJ , Epstein JB , Morton TH , Schwartz SM Interobserver reliability in the histopathologic diagnosis of oral pre-malignant and malignant lesions J Oral Pathol Med 2004 ; 33 ( 2 ): 65 – 70 [DOI] [PubMed] [Google Scholar]
  40. Abbey LM , Kaugars GE , Gunsolley JC , Burns JC , Page DG , Svirsky JA , et al. Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995 ; 80 ( 2 ): 188 – 191 [DOI] [PubMed] [Google Scholar]
  41. Fleskens S , Slootweg P Grading systems in head and neck dysplasia: their prognostic value, weaknesses and utility Head Neck Oncol 2009 ; 1 : 11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Pindborg JJ , Reibel J , Holmstrup P Subjectivity in evaluating oral epithelial dysplasia, carcinoma in situ and initial carcinoma J Oral Pathol 1985 ; 14 ( 9 ): 698 – 708 [DOI] [PubMed] [Google Scholar]
  43. Van Der Meij EH , Reibel J , Slootweg PJ , Van Der Wal JE , De Jong WFB , Van Der Waal I Interobserver and intraobserver variability in the histologic assessment of oral lichen planus J Oral Pathol Med 1999 ; 28 ( 6 ): 274 – 277 [DOI] [PubMed] [Google Scholar]
  44. Zohdy M , Cazzaniga S , Nievergelt H , Blum R , Suter VGA , Feldmeyer L , et al. Inter-observer and intra-observer variations in the assessment of epithelial dysplasia in oral lichenoid diseases Dermatopathol 2021 ; 8 ( 2 ): 84 – 88 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Journal of Dental Hygiene are provided here courtesy of Canadian Dental Hygienists Association

RESOURCES